- Heron Therapeutics to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
- Heron Therapeutics to Host Investor Day on May 15, 2024 in New York City
- Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
- Heron Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Updates
- Heron Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results On Tuesday, March 12, 2024
More ▼
Key statistics
As of last trade Heron Therapeutics Inc (HRTX:NAQ) traded at 2.47, -23.29% below its 52-week high of 3.22, set on Mar 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.62 |
---|---|
High | 2.63 |
Low | 2.45 |
Bid | 2.47 |
Offer | 2.48 |
Previous close | 2.55 |
Average volume | 2.58m |
---|---|
Shares outstanding | 150.33m |
Free float | 148.91m |
P/E (TTM) | -- |
Market cap | 383.34m USD |
EPS (TTM) | -0.8695 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 18:45 BST.
More ▼